Eric Joseph
Stock Analyst at Citi
(4.39)
# 1,245
Out of 5,078 analysts
348
Total ratings
49.2%
Success rate
9.8%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Reiterated: Buy | $360 → $330 | $243.37 | +35.60% | 3 | Oct 23, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $50 | $31.01 | +61.24% | 2 | Oct 23, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $100 | $42.93 | +132.94% | 6 | Oct 21, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Hold | $94 → $91 | $68.56 | +32.73% | 6 | Oct 20, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $340 → $320 | $224.03 | +42.84% | 6 | Oct 15, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $108 | $58.02 | +86.14% | 3 | Oct 14, 2026 | |
| MDGL Madrigal Pharmaceuticals | Initiated Coverage: Buy | $725 | $434.24 | +66.96% | 1 | Sep 23, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | n/a | $55.95 | - | 6 | Sep 14, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $99 | $61.23 | +61.69% | 3 | Jul 16, 2026 | |
| PTCT PTC Therapeutics | Initiated Coverage: Buy | $67 → $108 | $60.59 | +78.25% | 31 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $49 | $54.17 | -9.54% | 18 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.8636 | n/a | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $24.05 | n/a | 20 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $64 | $110.76 | n/a | 11 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $44 → $7 | $2.29 | n/a | 20 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $9.70 | n/a | 23 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.67 | n/a | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $18 | $3.30 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $40.41 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $11 | $18.18 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $10.57 | n/a | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.63 | n/a | 1 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $12 | $10.84 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $3.18 | n/a | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $70 | $186.99 | n/a | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $5 | $11.64 | n/a | 13 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $30 | $25.34 | n/a | 11 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $0.6001 | n/a | 11 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $7 | $3.06 | n/a | 6 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $10 | $3.70 | n/a | 6 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $5 | $1.46 | n/a | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $5 | $9.39 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $4.04 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $1.54 | n/a | 4 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $25.48 | n/a | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $0.5175 | n/a | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $4.78 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $13 | $3.46 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $7 | $1.88 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.5669 | n/a | 5 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $11 | $6.64 | n/a | 3 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $16.57 | n/a | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.0001 | n/a | 3 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 → $26 | $34.49 | n/a | 3 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.19 | n/a | 1 | Feb 7, 2020 |
Ascendis Pharma
Oct 23, 2026
Reiterated: Buy
Price Target: $360 → $330
Current: $243.37
Upside: +35.60%
Maze Therapeutics
Oct 23, 2026
Reiterated: Buy
Price Target: $50
Current: $31.01
Upside: +61.24%
Ionis Pharmaceuticals
Oct 21, 2026
Reiterated: Buy
Price Target: $100
Current: $42.93
Upside: +132.94%
BridgeBio Pharma
Oct 20, 2026
Reiterated: Hold
Price Target: $94 → $91
Current: $68.56
Upside: +32.73%
Alnylam Pharmaceuticals
Oct 15, 2026
Reiterated: Buy
Price Target: $340 → $320
Current: $224.03
Upside: +42.84%
Arrowhead Pharmaceuticals
Oct 14, 2026
Reiterated: Buy
Price Target: $108
Current: $58.02
Upside: +86.14%
Madrigal Pharmaceuticals
Sep 23, 2026
Initiated Coverage: Buy
Price Target: $725
Current: $434.24
Upside: +66.96%
BioMarin Pharmaceutical
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $55.95
Upside: -
Cytokinetics
Jul 16, 2026
Reiterated: Buy
Price Target: $99
Current: $61.23
Upside: +61.69%
PTC Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $67 → $108
Current: $60.59
Upside: +78.25%
Nov 3, 2025
Reiterated: Buy
Price Target: $46 → $49
Current: $54.17
Upside: -9.54%
Oct 10, 2025
Downgraded: Sell
Price Target: n/a
Current: $0.8636
Upside: n/a
Jun 25, 2025
Reiterated: Buy
Price Target: $48
Current: $24.05
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: $57 → $64
Current: $110.76
Upside: n/a
May 28, 2025
Downgraded: Hold
Price Target: $44 → $7
Current: $2.29
Upside: n/a
May 19, 2025
Reiterated: Sell
Price Target: $7
Current: $9.70
Upside: n/a
May 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $3.67
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $22 → $18
Current: $3.30
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $40.41
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $21 → $11
Current: $18.18
Upside: n/a
May 7, 2025
Reiterated: Hold
Price Target: $14
Current: $10.57
Upside: n/a
Apr 25, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.63
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $15 → $12
Current: $10.84
Upside: n/a
Mar 4, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $3.18
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $71 → $70
Current: $186.99
Upside: n/a
Feb 10, 2025
Reiterated: Sell
Price Target: $9 → $5
Current: $11.64
Upside: n/a
Jan 29, 2025
Reiterated: Buy
Price Target: $31 → $30
Current: $25.34
Upside: n/a
Dec 17, 2024
Reiterated: Hold
Price Target: $11
Current: $0.6001
Upside: n/a
Feb 23, 2024
Reiterated: Hold
Price Target: $6 → $7
Current: $3.06
Upside: n/a
Nov 13, 2023
Reiterated: Hold
Price Target: $11 → $10
Current: $3.70
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $28 → $5
Current: $1.46
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $15 → $5
Current: $9.39
Upside: n/a
Aug 10, 2023
Downgraded: Sell
Price Target: n/a
Current: $4.04
Upside: n/a
May 5, 2023
Reiterated: Hold
Price Target: $6 → $5
Current: $1.54
Upside: n/a
Nov 29, 2022
Downgraded: Sell
Price Target: n/a
Current: $25.48
Upside: n/a
Nov 4, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $0.5175
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $4.78
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $12 → $13
Current: $3.46
Upside: n/a
Mar 29, 2022
Reiterated: Buy
Price Target: $24 → $7
Current: $1.88
Upside: n/a
Mar 4, 2022
Reiterated: Sell
Price Target: n/a
Current: $0.5669
Upside: n/a
Nov 11, 2021
Reiterated: Hold
Price Target: $14 → $11
Current: $6.64
Upside: n/a
Oct 8, 2021
Downgraded: Sell
Price Target: n/a
Current: $16.57
Upside: n/a
Nov 9, 2020
Downgraded: Sell
Price Target: n/a
Current: $0.0001
Upside: n/a
Sep 21, 2020
Reiterated: Hold
Price Target: $39 → $26
Current: $34.49
Upside: n/a
Feb 7, 2020
Reiterated: Hold
Price Target: n/a
Current: $6.19
Upside: n/a